David Gintsburg

David Gintsburg

Auto-generated profile, based on publicly available information

David Gintsburg

Centre For Chemistry and Biomedicine (CCB) Department of Pharmaceutical Technology Institute of Pharmacy University of Innsbruck Innsbruck Austria

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2024 in Journal of Materials Chemistry B
Verified
Journal Article
Open access
PDF file
Mariana Blanco MassaniMariana Blanco Massani
Mariana Blanco Massani
DTDennis To
Dennis To
SMSusanne Meile
Susanne Meile
MSMathias Schmelcher
Mathias Schmelcher
DGDavid Gintsburg
David Gintsburg
ABAndreas Bernkop-Schnürch
Andreas Bernkop-Schnürch
Stimuli-responsive nanomaterials show promise in eradicating Staphylococcus aureus biofilm from implants. Peptidoglycan hydrolases (PGHs) are cationic antimicrobials that can be bioengineered to improve the targeting of persisters and drug-resistant bacteria. However, these molecules can be degraded before reaching the target and/or present limited efficacy against biofilm. Therefore, there is an urgent need to improve their potency. Herein, PGH–polyphosphate nanoparticles (PGH–PP NPs) are formed by ionotropic gelation between cationic PGHs and anionic polyphosphate, with the aim of protecting PHGs and delivering them at the target site triggered by alkaline phosphatase (AP) from S. aureus biofilm. Optimized conditions for obtaining M23–PP NPs and GH15–PP NPs are presented. Size, zeta potential, and transmission electron microscopy imaging confirm the nanoscale size. The system demonstrates outstanding performance, as evidenced by a dramatic reduction in PGHs’ minimum inhibitory concentration and minimum bactericidal concentration, together with protection against proteolytic effects, storage stability, and cytotoxicity towards the Caco-2 and HeLa cell lines. Time-kill experiments show the great potential of these negatively charged delivery systems in overcoming the staphylococcal biofilm barrier. Efficacy under conditions inhibiting AP proves the enzyme-triggered delivery of PGHs. The enzyme-responsive PGH–PP NPs significantly enhance the effectiveness of PGHs against bacteria residing in biofilm, offering a promising strategy for eradicating S. aureus biofilm.

28 October 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Open access
Gergely KaliGergely Kali
Gergely Kali
DGDavid Gintsburg
David Gintsburg
LMLana Molnar
Lana Molnar
AKAnnabelle Knoll
Annabelle Knoll
ABAndreas Bernkop-Schnürch
Andreas Bernkop-Schnürch

19 August 2025 in Carbohydrate Polymer Technologies and Applications
Verified
Journal Article
Open access
DGDavid Gintsburg
David Gintsburg
PKPia Kreuzer
Pia Kreuzer
KAKhush Bakhat Afzal
Khush Bakhat Afzal
IPIlaria Polidori
Ilaria Polidori
MTMartyna Truszkowska
Martyna Truszkowska
Gergely KaliGergely Kali
Gergely Kali

12 September 2025 in Advanced Healthcare Materials
Verified
Journal Article
Open access
Mariana Blanco MassaniMariana Blanco Massani
Mariana Blanco Massani
SMSusanne Meile
Susanne Meile
AKAnnabelle Knoll
Annabelle Knoll
DGDavid Gintsburg
David Gintsburg
IPIlaria Polidori
Ilaria Polidori
ABAndreas Bernkop-Schnürch
Andreas Bernkop-Schnürch
Hyaluronic acid (HA) is degraded by Staphylococcal hyaluronate lyase (Hysa) and mammalian hyaluronidase (Hyal). Thiolated HA (HAMS) is used as a targeted gateway for Staphylococcus aureus killing while enhancing the previous M23 endolysin–polyphosphate (M23‐PP NPs) enzyme‐responsive nanoparticle formulation. Synthesis of HAMS and characterization for nuclear magnetic resonance, solubility, thiol content, pKa, and degradation by Hysa and Hyal are presented. Nanoparticles prepared via ionotropic gelation between M23‐PP NPs and either HAMS or HA yield M23‐PP/HAMS or M23‐PP/HA NPs, respectively. Their characterization includes size, zeta potential, morphology, release profiles, safety, targeted release, and efficacy. HAMS with a thiol content of 250.18 ± 90.32 µmol g −1 , solubility of 50.99 ± 0.02 mg mL −1 , exhibits pKa values of 3.2, 4.2, and 8.8. This thiolated polymer irreversibly inhibits Hyal activity, without affecting Hysa. M23‐PP/HAMS NPs (265 ± 47 nm, −25 mV) maintain their integrity for seven days at 37 °C, and HAMS coating prevents nonspecific degradation by Hyal, as confirmed by release studies. In a co‐culture ‘race for the surface’ experiment with MC3T3 osteoblasts and S. aureus ATCC 25923, M23‐PP/HAMS NPs produce 8‐log bacterial killing while promoting in vitro wound healing. These findings are pivotal to the development of new enzyme‐responsive excipients switchable by S. aureus .

8 June 2026 in Carbohydrate Polymer Technologies and Applications
Verified
Journal Article
Open access
AKAnnabelle Knoll
Annabelle Knoll
DGDavid Gintsburg
David Gintsburg
SKStefan Keim
Stefan Keim
RFRaphael Fischer
Raphael Fischer
PHPatrizia Harlander
Patrizia Harlander
ABAndreas Bernkop-Schnürch
Andreas Bernkop-Schnürch

15 January 2026 in Carbohydrate Polymer Technologies and Applications
Verified
Journal Article
Open access
Mariana Blanco MassaniMariana Blanco Massani
Mariana Blanco Massani
DTDennis To
Dennis To
DGDavid Gintsburg
David Gintsburg
LMLana Molnar
Lana Molnar
IPIlaria Polidori
Ilaria Polidori
ABAndreas Bernkop-Schnürch
Andreas Bernkop-Schnürch